These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20610323)

  • 1. The deadly synergy of HIV and tuberculosis.
    Lancet Infect Dis; 2010 Jul; 10(7):441. PubMed ID: 20610323
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV.
    Sawry S; Moultrie H; Van Rie A
    Int J Tuberc Lung Dis; 2018 Nov; 22(11):1322-1328. PubMed ID: 30355412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy.
    Sacks HS
    Ann Intern Med; 2014 Sep; 161(6):JC12. PubMed ID: 25222412
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventive treatment for tuberculosis in people with HIV.
    Swaminathan S
    Lancet; 2014 Aug; 384(9944):644-6. PubMed ID: 24835843
    [No Abstract]   [Full Text] [Related]  

  • 5. Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
    Granich R; Getahun H; Reid A; Raviglione M; De Cock KM
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):925-6. PubMed ID: 19723370
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes in HIV-infected patients who develop tuberculosis after starting antiretroviral treatment in Malawi.
    Yu JK; Bong CN; Chen SC; Dzimadzi R; Lu DY; Makombe SD; Schouten EJ; Kamoto K; Harries AD
    Int J Tuberc Lung Dis; 2008 Jun; 12(6):692-4. PubMed ID: 18492340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

  • 8. [The epidemiology of tuberculosis and of the resistance to antitubercular agents].
    Aït Khaled N; Enarson D; Billo N
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S8-18. PubMed ID: 9496587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis control in South Africa--time for a new paradigm?
    Wilkinson D; De Cock KM
    S Afr Med J; 1996 Jan; 86(1):33-5. PubMed ID: 8685778
    [No Abstract]   [Full Text] [Related]  

  • 10. The International Tuberculosis Surveillance Research Unit (TSRU): the first 30 years.
    Rouillon A
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):5-9. PubMed ID: 9562105
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing mortality from HIV infection and tuberculosis.
    Koole O; Colebunders R
    Lancet Infect Dis; 2011 Jul; 11(7):494-5. PubMed ID: 21514235
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV infection, tuberculosis and non-tuberculous mycobacteria.
    Churchyard GJ; Grant AD
    S Afr Med J; 2000 May; 90(5):472-6. PubMed ID: 10901814
    [No Abstract]   [Full Text] [Related]  

  • 13. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding.
    Hanifa Y; Fielding KL; Charalambous S; Variava E; Luke B; Churchyard GJ; Grant AD
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1252-9. PubMed ID: 22794030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care.
    Louwagie G; Girdler-Brown B; Odendaal R; Rossouw T; Johnson S; Van der Walt M
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1052-8. PubMed ID: 22691870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.
    Lester R; Hamilton R; Charalambous S; Dwadwa T; Chandler C; Churchyard GJ; Grant AD
    AIDS; 2010 Nov; 24 Suppl 5():S45-8. PubMed ID: 21079427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
    Aguado JM; Pulido F; Moreno S
    N Engl J Med; 1997 Dec; 337(23):1696-7; author reply 1697. PubMed ID: 9411240
    [No Abstract]   [Full Text] [Related]  

  • 17. Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
    Dore GJ; Law MG; Kaldor JM
    N Engl J Med; 1997 Dec; 337(23):1697. PubMed ID: 9411241
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary: Reducing HIV-associated tuberculosis in children.
    Boulle A; Eley B
    Int J Epidemiol; 2009 Dec; 38(6):1621-3. PubMed ID: 19755397
    [No Abstract]   [Full Text] [Related]  

  • 19. The HIV-associated tuberculosis epidemic--when will we act?
    Harries AD; Zachariah R; Corbett EL; Lawn SD; Santos-Filho ET; Chimzizi R; Harrington M; Maher D; Williams BG; De Cock KM
    Lancet; 2010 May; 375(9729):1906-19. PubMed ID: 20488516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of tuberculosis in India.
    Mohapatra PR
    Lancet; 2003 Oct; 362(9391):1243. PubMed ID: 14568763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.